New gel could ease rare skin condition in phase 3 trial
NCT ID NCT06239480
First seen Mar 29, 2026 · Last updated Apr 29, 2026 · Updated 4 times
Summary
This study tests a gel called QTORIN 3.9% rapamycin on people aged 3 and older with microcystic lymphatic malformations, a rare skin condition causing fluid-filled bumps. The main goal is to see if the gel improves the condition after 24 weeks of daily use. About 51 participants will apply the gel at home, and doctors will check their skin regularly. This is a phase 3 trial, meaning it's the final step before seeking approval for wider use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MICROCYSTIC LYMPHATIC MALFORMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Healthcare of Atlanta
Atlanta, Georgia, 30342, United States
-
Children's Hospital of Orange County
Irvine, California, 92612, United States
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
Cincinnati Children's Hospital
Cincinnati, Ohio, 45229, United States
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Minnesota Clinical Study Center
New Brighton, Minnesota, 55112, United States
-
Penn State Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Stanford University
Palo Alto, California, 94305, United States
-
Texas Children's Hospital
Houston, Texas, 77030, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27516, United States
-
University of Texas, Dell Children's
Austin, Texas, 78723, United States
-
University of Utah Health
Salt Lake City, Utah, 84113, United States
-
Vanderbilt Children's Hospital
Nashville, Tennessee, 37232, United States
-
Vascular Birthmark Institute
New York, New York, 10016, United States
Conditions
Explore the condition pages connected to this study.